- Home
- OGE vs CORT Comparison
OGE vs CORT Comparison
Compare OGE & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OGE | CORT |
|---|---|---|
| Founded | 1902 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 7.6B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | OGE | CORT |
|---|---|---|
| Price | $43.11 | $82.07 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 6 |
| Target Price | $48.56 | ★ $130.20 |
| AVG Volume (30 Days) | ★ 1.6M | 821.3K |
| Earning Date | 10-29-2025 | 11-04-2025 |
| Dividend Yield | ★ 3.95% | N/A |
| EPS Growth | ★ 29.01 | N/A |
| EPS | ★ 2.49 | 0.87 |
| Revenue | ★ $3,294,800,000.00 | $741,172,000.00 |
| Revenue This Year | $7.16 | $23.79 |
| Revenue Next Year | $4.28 | $40.97 |
| P/E Ratio | ★ $17.29 | $92.87 |
| Revenue Growth | ★ 18.03 | 17.92 |
| 52 Week Low | $39.41 | $49.00 |
| 52 Week High | $47.33 | $117.33 |
Technical Indicators
Market Signals| Indicator | OGE | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 39.31 | 51.62 |
| Support Level | $42.73 | $78.07 |
| Resistance Level | $43.51 | $89.00 |
| Average True Range (ATR) | 0.61 | 3.40 |
| MACD | -0.06 | -0.11 |
| Stochastic Oscillator | 17.16 | 39.42 |
Price Performance
Historical ComparisonAbout OGE OGE Energy Corp
OGE Energy is a holding company for Oklahoma Gas & Electric, a regulated utility with electricity generation, transmission, and distribution service for 900,000 customers in Oklahoma and western Arkansas. In December 2021, OGE divested its 25.5% stake in Enable Midstream Partners, an oil and gas services company it created in 2013 through a unit exchange merger with Energy Transfer. OGE sold its 95.4 million limited partner units of Energy Transfer throughout 2022. OGE sold its retail gas business in 1928 and no longer has any gas operations.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.